4.6 Review

The epigenetic, code replication machinery, ECREM: A promising drugable target of the epigenetic cell memory

期刊

CURRENT MEDICINAL CHEMISTRY
卷 14, 期 25, 页码 2629-2641

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986707782023244

关键词

canter; DNA methyltransferase; drug; epigenetic; histone code; histone deacetylases; histone acetyltransferases; inhibitors; neuro-degenerative disorders; sirtuins; therapy

向作者/读者索取更多资源

Discrete chemical modifications of the chromatin (DNA and primarily histories) can regulate gene expression or repression and can be transmitted to the descent (tells or organisms) thanks to an epigenetic memory. These modifications involve histone post-translational modifications, DNA methylation at CpG islands and small nuclear RNAs processes. They play fundamental roles in cell proliferation and differentiation. These two processes are crucial in particular during embryonic development, X chromosome inactivation in females, genomic imprinting, gene bookmarking, cell reprogramming, position effect and silencing of retroviral elements. While, only one major DNA modification is known, more than 150 post-translation modifications of histories have been reported, including methylations, acetylations, ubiquitinations, SUMOylations and phosphorylations. How these modifications are inherited from mother cells to daughter cells or from an organism to its descent remains a major scientific challenge. We propose here a macro-molecular complex, called ECREM for Epigenetic Code REplication Machinery, as being involved in the inheritance of the epigenetic code. The composition of ECREM may vary in a spatio-temporal manner according to the chromatin state, the cell phenotype and the development stage. We describe the members of ECREM, responsible for the epigenetic code inheritance, i.e., enzymes involved in DNA methylation and histone post-translational modifications. Some of them, such as DNA methyltransferases (DNMTs), historic acetyltransferases (HATs) and histone deacetylases (HDACS including sirtuins), have been found to be deregulated in several types of pathologies and are already targeted by inhibitors. ECREM, thus, appears to be an interesting complex to be investigated in order to find new drugs for cancer, metabolic, neuro-degenerative and inflammatory diseases therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据